Drug Shortage Report for TARO-MEROPENEM
| Report ID | 175755 |
| Drug Identification Number | 02421518 |
| Brand name | TARO-MEROPENEM |
| Common or Proper name | MEROPENEM |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MEROPENEM |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10X1V |
| ATC code | J01DH |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-05-01 |
| Estimated end date | 2023-07-16 |
| Actual end date | 2023-07-16 |
| Shortage status | Resolved |
| Updated date | 2023-07-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-11-25 | French | Compare |
| v1 | 2022-11-25 | English | Compare |